Oncology Meeting Resources

In this section, you can find all available abstracts, presentations and webcasts on OncologyPRO.

Here below, you can search across all meeting resources by session title, presentation title, presenter or keyword. Results can then be refined by topic, event and publication date.

The use of these presentations is for personal educational purposes only.
ESMO thanks the authors for their generosity.




Format available

http://oncologypro.esmo.org/Meeting-Resourc...m-2018/Insights-to-Sarcoma-and-GIST-in-India

Date: 07 Feb 2018
Presenter: Nikhil Guhagarkar
Resources: Presentation, Webcast
Topics: GIST, Cancer Aetiology, Epidemiology, Prevention, Sarcoma

http://oncologypro.esmo.org/Meeting-Resourc...mposium-2018/The-natural-history-of-STS-GIST

Date: 05 Feb 2018
Presenter: Paolo G. Casali
Resources: Presentation, Webcast
Topics: Soft Tissue Sarcomas, GIST, Cancer Aetiology, Epidemiology, Prevention, Sarcoma

http://oncologypro.esmo.org/Meeting-Resourc...ano-November-2017/Systemic-T-cell-Lymphomas2

Date: 13 Dec 2017
Presenter: M. Federico, IT
Resources: Presentation
Topics: Haematologic Malignancies, Lymphomas, Cancer Aetiology, Epidemiology, Prevention, Anti-Cancer Agents & Biologic Therapy

http://oncologypro.esmo.org/Meeting-Resourc...ion-and-Screening-of-Long-Term-Side-Effects2

Date: 13 Dec 2017
Presenter: L. Specht, DK
Resources: Presentation
Topics: Haematologic Malignancies, Lymphomas, Cancer Aetiology, Epidemiology, Prevention

http://oncologypro.esmo.org/Meeting-Resourc...ma-Classification-and-the-2016-WHO-Revision2

Date: 13 Dec 2017
Presenter: E. Campo, ES
Resources: Presentation
Topics: Haematologic Malignancies, Lymphomas, Cancer Aetiology, Epidemiology, Prevention

http://oncologypro.esmo.org/Meeting-Resourc...-ESMO-objectives-and-scientific-introduction

Date: 13 Dec 2017
Presenter: M. Ghielmini, CH
Resources: Presentation
Topics: Haematologic Malignancies, Lymphomas, Cancer Aetiology, Epidemiology, Prevention

http://oncologypro.esmo.org/Meeting-Resourc...ession-Invited-Discussant-13PD-14PD-and-18PD

Date: 09 Dec 2017
Presenter: Jeffrey Weber
Resources: Presentation, Webcast
Topics: Bioethics, Legal, and Economic Issues, Cancer Aetiology, Epidemiology, Prevention

http://oncologypro.esmo.org/Meeting-Resourc...al-world-The-Northern-Ireland-experience-22P

BackgroundIpilimumab was the first immune checkpoint inhibitor to demonstrate a survival benefit for metastatic melanoma patients and has been available in Northern Ireland (NI) since 2012.

Date: 08 Dec 2017
Presenter: Peter Gallagher
Resources: Abstract
Topics: Bioethics, Legal, and Economic Issues, Cancer Aetiology, Epidemiology, Prevention

http://oncologypro.esmo.org/Meeting-Resourc...n-patients-with-solid-tumor-malignancies-35P

BackgroundImmunotherapy has been a beacon of hope for many cancers. Recent trials have suggested that PD-L1 expression measured by IHC may predict response to anti-PD 1 (PD-1 & PDL-1) therapy.

Date: 08 Dec 2017
Presenter: Shayma Kazmi
Resources: Abstract
Topics: Bioethics, Legal, and Economic Issues, Cancer Aetiology, Epidemiology, Prevention

http://oncologypro.esmo.org/Meeting-Resourc...-an-off-the-self-cell-based-drug-product-64P

BackgroundPDC*vac is a patented technology relying on the use of PDC*line, a HLA-A*02:01+ plasmacytoïd Dendritic Cell (PDC) line, as a potent antigen presenting cell to strongly boost T cell responses both in vitro and in vivo.

Date: 08 Dec 2017
Presenter: Joel Plumas
Resources: Abstract
Topics: Lymphomas, Cancer Aetiology, Epidemiology, Prevention, Haematologic Malignancies, Pathology/Molecular Biology